Zenabis

HEXO Reports Q4’22 and FY22 Financial Results

Retrieved on: 
Tuesday, November 1, 2022

GATINEAU, Québec, Oct. 31, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, today reported its financial results for the fourth quarter (“Q4’22”) and fiscal year ended July 31, 2022 ("FY22"). All currency amounts are stated in Canadian thousands unless otherwise noted.

Key Points: 
  • GATINEAU, Qubec, Oct. 31, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the Company"), a leading producer of high-quality cannabis products, today reported its financial results for the fourth quarter (Q422) and fiscal year ended July 31, 2022 ("FY22").
  • The fourth quarter was a period of strategic realignment for HEXO, said Charlie Bowman, President and CEO of HEXO.
  • Re-financing of the senior secured convertible note deleverage the balance sheet and boosted cash reserves, allowing us to focus on profitable growth, said Julius Ivancsits, Acting Chief Financial Officer of HEXO.
  • HEXO recorded net revenue in FY22 of $191.1 million, up from $123.8 million from the fiscal year ended July 31, 2021 (FY21).

HEXO Announces Filing of Early Warning Report in Respect of the Former Zenabis Global Inc.

Retrieved on: 
Tuesday, November 1, 2022

HEXO understands that, as part of the pre-closing steps approved by the Zenabis Approval and Vesting Order, Zenabis amalgamated with certain other companies within the Zenabis Group to form Zenabis Ltd. (AmalCo).

Key Points: 
  • HEXO understands that, as part of the pre-closing steps approved by the Zenabis Approval and Vesting Order, Zenabis amalgamated with certain other companies within the Zenabis Group to form Zenabis Ltd. (AmalCo).
  • HEXO is an award-winning licensed producer of innovative products for the global cannabis market.
  • The Company also serves the Colorado market through its Powered by HEXO strategy and Truss CBD USA, a joint venture with Molson-Coors.
  • With the completion of HEXO's acquisitions of Redecan and 48North, HEXO is a leading cannabis products company in Canada by recreational market share.

HEXO Provides Nasdaq Listing Update

Retrieved on: 
Monday, January 31, 2022

GATINEAU, Québec, Jan. 31, 2022 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO", or the "Company") (TSX: HEXO; NASDAQ: HEXO), today announced that it received notification (the “Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirement in Nasdaq Listing Rule 5500(a)(2) for continued listing on the Nasdaq Capital Market, since the closing bid price for the Company’s common shares listed on Nasdaq was below US$1.00 for 30 consecutive trading days. Nasdaq Listing Rule 5550(a)(2) requires the common shares to maintain a minimum bid price of US$1.00 per share (the “Minimum Bid Requirement”), and Nasdaq Listing Rule 5810(c)(3)(A) provides that failure to meet such requirement exists if the deficiency continues for a period of 30 consecutive business days.

Key Points: 
  • GATINEAU, Qubec, Jan. 31, 2022 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO", or the "Company") (TSX: HEXO; NASDAQ: HEXO), today announced that it received notification (the Notification) from The Nasdaq Stock Market LLC (Nasdaq) that it is not in compliance with the minimum bid price requirement in Nasdaq Listing Rule 5500(a)(2) for continued listing on the Nasdaq Capital Market, since the closing bid price for the Companys common shares listed on Nasdaq was below US$1.00 for 30 consecutive trading days.
  • Nasdaq Listing Rule 5550(a)(2) requires the common shares to maintain a minimum bid price of US$1.00 per share (the Minimum Bid Requirement), and Nasdaq Listing Rule 5810(c)(3)(A) provides that failure to meet such requirement exists if the deficiency continues for a period of 30 consecutive business days.
  • The Notification has no immediate effect on the listing of the Companys common shares on the Nasdaq Capital Market.
  • Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from the date of Notification, being until July 25, 2022, to regain compliance with the Minimum Bid Requirement, during which time the common shares will continue to trade on the Nasdaq Capital Market.

HEXO Provides Integration Update

Retrieved on: 
Tuesday, November 9, 2021

OTTAWA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (HEXO, or the Company) (TSX: HEXO; NASDAQ: HEXO), today provided an update on the execution of its ongoing integration plan following its recent acquisitions of Redecan, Zenabis Global Inc. (Zenabis) and 48North Cannabis Corp. (48North).

Key Points: 
  • OTTAWA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (HEXO, or the Company) (TSX: HEXO; NASDAQ: HEXO), today provided an update on the execution of its ongoing integration plan following its recent acquisitions of Redecan, Zenabis Global Inc. (Zenabis) and 48North Cannabis Corp. (48North).
  • In the coming months, HEXO will cease operations at three production sites to centralize product cultivation, manufacturing, and distribution at its core facilities.
  • "As part of the integration planning process, we completed a comprehensive evaluation of all HEXO facilities to review their capabilities, capacity, and efficiency, and made the decision to centralize operations at our core facilities.
  • This was a very difficult decision, but it is a key component of our integration plan, and one that we believe best positions HEXO for continued growth.

HEXO Reports Fourth Quarter and Fiscal Year 2021 Financial Results Highlighting Strong Growth

Retrieved on: 
Friday, October 29, 2021

Total net sales growth of 71% quarter-over-quarter and 43% from Q420, marking HEXO's best quarter of sales to date.

Key Points: 
  • Total net sales growth of 71% quarter-over-quarter and 43% from Q420, marking HEXO's best quarter of sales to date.
  • Completed the acquisition of Zenabis Global Inc. (Zenabis)
    OTTAWA, Oct. 29, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the "Company") today reported its financial results for the fourth quarter (Q421) and fiscal year ended July 31, 2021 ("F21").
  • HEXO also announced the appointment of Valerie Malone as Chief Commercial Officer and Guillaume Jouet as Chief People & Culture Officer.
  • Key Highlights to July 31, 2021
    On June 28, 2021, HEXO announced the closing of the acquisition of a 50,000 sq.

Zenabis Announces the Establishment of an At-the-Market Equity Offering Program

Retrieved on: 
Wednesday, February 10, 2021

The volume and timing of distributions under the ATM Program, if any, will be determined in the Companys sole discretion.

Key Points: 
  • The volume and timing of distributions under the ATM Program, if any, will be determined in the Companys sole discretion.
  • The Company expects to use the net proceeds from the ATM Program for general corporate purposes and working capital needs.
  • Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Langley, British Columbia; and Stellarton, Nova Scotia.
  • Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release.

MPX International’s Wholly-Owned Subsidiary, Canveda Inc., Enters Into a Purchase Agreement With Zenabis Ltd. for the Supply of Cannabis

Retrieved on: 
Wednesday, August 12, 2020

MPX International has a strong presence in the international cannabis market and we have identified several international opportunities that are interested in purchasing Canadian cannabis.

Key Points: 
  • MPX International has a strong presence in the international cannabis market and we have identified several international opportunities that are interested in purchasing Canadian cannabis.
  • The supply agreement between the parties secures Canveda 300 1,000 kg of cannabis flower per calendar quarter.
  • Canveda has entered into supply agreements with the Provincial Governments of Alberta and Saskatchewan to supply high quality flower.
  • Zenabis expects its Zenabis Atholville, Zenabis Stellarton and Zenabis Langley facilities to be in steady state production in 2020.